Earlier this week, BBRC International, which owns 12.9% of Victoria’s Secret & Co, publicly called for the removal of Board Chair Donna James and demanded a board seat for its founder Brett Blundy, following months of unsuccessful private engagement with the Board.

This escalation marks a significant shift in shareholder activism at Victoria’s Secret, bringing corporate governance issues and board composition into the public spotlight.

We'll explore how BBRC’s demand for board representation and leadership change could influence Victoria’s Secret’s long-term growth and transformation plans.

Uncover the next big thing with financially sound penny stocks that balance risk and reward.

To be a shareholder of Victoria’s Secret, you need confidence in its ongoing transformation, especially its push for inclusivity and omnichannel growth, to offset challenges like slower revenue growth and margin pressure from tariffs. The recent public push by BBRC International for board changes brings near-term uncertainty, but unless it results in major management disruption or distracts from operational initiatives, it is unlikely to materially impact the most important catalyst for the business: execution of digital and international expansion. The biggest risk remains unmitigated margin headwinds from tariffs and pressure on mall-based operations, both of which could be affected if the company’s focus shifts due to governance debates.

The company’s latest Q2 earnings announcement is especially relevant here, as Victoria’s Secret delivered sales and margin growth that beat expectations despite persistent tariff headwinds. This shows that, even under the current leadership, the Path to Potential strategy continues to provide momentum behind the key growth initiatives BBRC’s push could influence. The ongoing margin improvements amid industry pressures make stability at the board level an important factor for any investor who sees value in the company’s evolution.

However, looking past the headlines, the risk of prolonged governance disputes distracting from store concept upgrades and digital transformation is something investors should not lose sight of if ...

Read the full narrative on Victoria's Secret (it's free!)

Victoria's Secret's outlook projects $6.7 billion in revenue and $143.6 million in earnings by 2028. This is based on an expected annual revenue growth rate of 2.2%, but reflects a decrease in earnings of $7.8 million from the current $151.4 million.

Uncover how Victoria's Secret's forecasts yield a $29.00 fair value, a 20% downside to its current price.

Simply Wall St Community members provided five different fair value estimates for Victoria's Secret, ranging from US$23.84 to US$46.19 per share. While perspectives vary, ongoing shareholder activism could influence how well the company manages margin pressures and transformation, so consider diverse viewpoints before making your own assessment.

Explore 5 other fair value estimates on Victoria's Secret - why the stock might be worth 34% less than the current price!

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

A great starting point for your Victoria's Secret research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.

Our free Victoria's Secret research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Victoria's Secret's overall financial health at a glance.

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 25 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include VSCO.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com